PDB Short entry for 4W8E HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-AUG-14 4W8E TITLE STRUCTURE OF MST3 WITH A PYRROLOPYRIMIDINE INHIBITOR (PF-06645342) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24 36 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 9-298; COMPND 5 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3 N-TERMINAL, MST-3/N; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MST3, PYRROLOPYRIMIDINE, KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.JASTI,X.SONG,M.GRIFFOR,R.G.KURUMBAIL REVDAT 1 18-MAR-15 4W8E 0 JRNL AUTH J.L.HENDERSON,B.L.KORMOS,M.M.HAYWARD,K.J.COFFMAN,J.JASTI, JRNL AUTH 2 R.G.KURUMBAIL,T.T.WAGER,P.R.VERHOEST,G.S.NOELL,Y.CHEN, JRNL AUTH 3 E.NEEDLE,Z.BERGER,S.J.STEYN,C.HOULE,W.D.HIRST,P.GALATSIS JRNL TITL DISCOVERY AND PRECLINICAL PROFILING OF JRNL TITL 2 3-[4-(MORPHOLIN-4-YL)-7H-PYRROLO[2, JRNL TITL 3 3-D]PYRIMIDIN-5-YL]BENZONITRILE (PF-06447475), A HIGHLY JRNL TITL 4 POTENT, SELECTIVE, BRAIN PENETRANT, AND IN VIVO ACTIVE LRRK2 JRNL TITL 5 KINASE INHIBITOR. JRNL REF J.MED.CHEM. V. 58 419 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25353650 JRNL DOI 10.1021/JM5014055 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 27227 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1389 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.86 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.45 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2680 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2225 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2547 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE : 0.2528 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.96 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 133 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2325 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.22980 REMARK 3 B22 (A**2) : -7.15870 REMARK 3 B33 (A**2) : 0.92890 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.31550 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.228 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.127 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.119 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.124 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.119 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2407 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3256 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 859 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 63 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 360 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2407 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 311 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2970 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.07 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 7.8471 22.5126 12.1249 REMARK 3 T TENSOR REMARK 3 T11: -0.0936 T22: -0.0947 REMARK 3 T33: -0.0726 T12: -0.0073 REMARK 3 T13: -0.0063 T23: 0.0050 REMARK 3 L TENSOR REMARK 3 L11: 1.4772 L22: 1.6507 REMARK 3 L33: 1.3011 L12: -0.8782 REMARK 3 L13: -0.6476 L23: 0.8661 REMARK 3 S TENSOR REMARK 3 S11: -0.0188 S12: -0.1178 S13: 0.1056 REMARK 3 S21: 0.1810 S22: 0.0430 S23: -0.0685 REMARK 3 S31: -0.0284 S32: 0.0373 S33: -0.0242 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4W8E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000203373. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27257 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 43.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.02300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL (PH 8.5), 180MM MGCL2, REMARK 280 5MM MANGANESE ACETATE, 10-17% PEG3350, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.24500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -149.81 -117.03 REMARK 500 PHE A 35 -13.70 69.61 REMARK 500 GLU A 61 -58.41 -131.02 REMARK 500 ASP A 92 -117.44 58.76 REMARK 500 ARG A 143 -0.95 72.46 REMARK 500 ASP A 162 84.32 62.36 REMARK 500 ASP A 197 -151.31 -143.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3JB A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4W8D RELATED DB: PDB DBREF 4W8E A 9 299 UNP Q9Y6E0 STK24_HUMAN 9 299 SEQRES 1 A 291 GLY LEU PRO GLY MET GLN ASN LEU LYS ALA ASP PRO GLU SEQRES 2 A 291 GLU LEU PHE THR LYS LEU GLU LYS ILE GLY LYS GLY SER SEQRES 3 A 291 PHE GLY GLU VAL PHE LYS GLY ILE ASP ASN ARG THR GLN SEQRES 4 A 291 LYS VAL VAL ALA ILE LYS ILE ILE ASP LEU GLU GLU ALA SEQRES 5 A 291 GLU ASP GLU ILE GLU ASP ILE GLN GLN GLU ILE THR VAL SEQRES 6 A 291 LEU SER GLN CYS ASP SER PRO TYR VAL THR LYS TYR TYR SEQRES 7 A 291 GLY SER TYR LEU LYS ASP THR LYS LEU TRP ILE ILE MET SEQRES 8 A 291 GLU TYR LEU GLY GLY GLY SER ALA LEU ASP LEU LEU GLU SEQRES 9 A 291 PRO GLY PRO LEU ASP GLU THR GLN ILE ALA THR ILE LEU SEQRES 10 A 291 ARG GLU ILE LEU LYS GLY LEU ASP TYR LEU HIS SER GLU SEQRES 11 A 291 LYS LYS ILE HIS ARG ASP ILE LYS ALA ALA ASN VAL LEU SEQRES 12 A 291 LEU SER GLU HIS GLY GLU VAL LYS LEU ALA ASP PHE GLY SEQRES 13 A 291 VAL ALA GLY GLN LEU THR ASP THR GLN ILE LYS ARG ASN SEQRES 14 A 291 TPO PHE VAL GLY THR PRO PHE TRP MET ALA PRO GLU VAL SEQRES 15 A 291 ILE LYS GLN SER ALA TYR ASP SER LYS ALA ASP ILE TRP SEQRES 16 A 291 SER LEU GLY ILE THR ALA ILE GLU LEU ALA ARG GLY GLU SEQRES 17 A 291 PRO PRO HIS SER GLU LEU HIS PRO MET LYS VAL LEU PHE SEQRES 18 A 291 LEU ILE PRO LYS ASN ASN PRO PRO THR LEU GLU GLY ASN SEQRES 19 A 291 TYR SER LYS PRO LEU LYS GLU PHE VAL GLU ALA CYS LEU SEQRES 20 A 291 ASN LYS GLU PRO SER PHE ARG PRO THR ALA LYS GLU LEU SEQRES 21 A 291 LEU LYS HIS LYS PHE ILE LEU ARG ASN ALA LYS LYS THR SEQRES 22 A 291 SER TYR LEU THR GLU LEU ILE ASP ARG TYR LYS ARG TRP SEQRES 23 A 291 LYS ALA GLU GLN SER MODRES 4W8E TPO A 178 THR MODIFIED RESIDUE HET TPO A 178 11 HET 3JB A 500 29 HETNAM TPO PHOSPHOTHREONINE HETNAM 3JB 3-{4-[(2R)-2-(5-METHYL-1,2,4-OXADIAZOL-3-YL)MORPHOLIN- HETNAM 2 3JB 4-YL]-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL}BENZONITRILE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 3JB C20 H17 N7 O2 FORMUL 3 HOH *221(H2 O) HELIX 1 AA1 PRO A 20 GLU A 22 5 3 HELIX 2 AA2 GLU A 63 CYS A 77 1 15 HELIX 3 AA3 ALA A 107 GLU A 112 1 6 HELIX 4 AA4 ASP A 117 GLU A 138 1 22 HELIX 5 AA5 LYS A 146 ALA A 148 5 3 HELIX 6 AA6 THR A 182 MET A 186 5 5 HELIX 7 AA7 ALA A 187 LYS A 192 1 6 HELIX 8 AA8 SER A 198 GLY A 215 1 18 HELIX 9 AA9 HIS A 223 ASN A 234 1 12 HELIX 10 AB1 SER A 244 LEU A 255 1 12 HELIX 11 AB2 GLU A 258 ARG A 262 5 5 HELIX 12 AB3 THR A 264 LEU A 269 1 6 HELIX 13 AB4 HIS A 271 ALA A 278 1 8 HELIX 14 AB5 LYS A 280 TYR A 283 5 4 HELIX 15 AB6 LEU A 284 GLN A 298 1 15 SHEET 1 AA1 6 LYS A 17 ALA A 18 0 SHEET 2 AA1 6 TYR A 85 LYS A 91 1 O SER A 88 N LYS A 17 SHEET 3 AA1 6 LYS A 94 GLU A 100 -1 O LYS A 94 N LYS A 91 SHEET 4 AA1 6 VAL A 49 ASP A 56 -1 N ALA A 51 O MET A 99 SHEET 5 AA1 6 GLU A 37 ASP A 43 -1 N PHE A 39 O ILE A 52 SHEET 6 AA1 6 PHE A 24 LYS A 32 -1 N GLU A 28 O LYS A 40 SHEET 1 AA2 3 GLY A 105 SER A 106 0 SHEET 2 AA2 3 VAL A 150 LEU A 152 -1 O LEU A 152 N GLY A 105 SHEET 3 AA2 3 VAL A 158 LEU A 160 -1 O LYS A 159 N LEU A 151 SHEET 1 AA3 2 LYS A 140 ILE A 141 0 SHEET 2 AA3 2 GLY A 167 GLN A 168 -1 O GLY A 167 N ILE A 141 LINK C ASN A 177 N TPO A 178 1555 1555 1.34 LINK C TPO A 178 N PHE A 179 1555 1555 1.35 SITE 1 AC1 15 ILE A 30 GLY A 31 LYS A 32 ALA A 51 SITE 2 AC1 15 LYS A 53 GLU A 70 GLU A 100 TYR A 101 SITE 3 AC1 15 LEU A 102 LEU A 151 ASP A 162 HOH A 788 SITE 4 AC1 15 HOH A 810 HOH A 814 HOH A 819 CRYST1 47.530 56.490 61.060 90.00 111.41 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021039 0.000000 0.008249 0.00000 SCALE2 0.000000 0.017702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017591 0.00000